Sugi Predict

Sugi Predict / Compounds / SCHEMBL8417604

SCHEMBL8417604

SCHEMBL8417604

C=CCCCN(CC)CC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.50
▸ ALDH1A1 P00352 3/20 0.50
▸ MEN1 O00255 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SIGMAR1 Q99720 1/20 0.33
▸ SLC2A1 P11166 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.31
▸ CHRM1 P11229 2/20 0.31
▸ SLC6A2 P23975 2/20 0.31
▸ SLC6A4 P31645 2/20 0.31
▸ ADRA1A P35348 2/20 0.31
▸ OPRM1 P35372 2/20 0.31
▸ DRD3 P35462 2/20 0.31
▸ SLC6A3 Q01959 2/20 0.31
▸ KCNH2 Q12809 2/20 0.31
▸ CHRM2 P08172 1/20 0.31
▸ HTR1A P08908 1/20 0.31
▸ ADRA2A P08913 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL22771826 0.97 TSHR (0.48) TSHRALDH1A1MEN1POLBKMT2A
SCHEMBL3116198 0.92 TSHR (0.50) TSHRALDH1A1MEN1POLBKMT2A
SCHEMBL3121690 0.90 TSHR (0.54) TSHRALDH1A1MEN1POLBKMT2A
SCHEMBL3110270 0.90 TSHR (0.54) TSHRALDH1A1MEN1POLBKMT2A
SCHEMBL3108938 0.90 TSHR (0.54) TSHRALDH1A1MEN1POLBKMT2A
Iodide SCHEMBL10492763 0.90 TSHR (0.48) TSHRALDH1A1MEN1POLBKMT2A
SCHEMBL3125534 0.90 TSHR (0.54) TSHRALDH1A1MEN1POLBKMT2A
SCHEMBL3116973 0.90 TSHR (0.54) TSHRALDH1A1MEN1POLBKMT2A
SCHEMBL3116519 0.90 TSHR (0.54) TSHRALDH1A1MEN1POLBKMT2A
SCHEMBL22157599 0.88 TSHR (0.50) TSHRALDH1A1MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117343477-A Curable composition and application thereof 益丰新材料股份有限公司 2024-01-05 — — CN claimed
CN-108623898-A The spacer bar of antimildew and antibacterial polypropylene material and preparation method with the application material 石家庄欧强节能建材科技有限公司 2018-10-09 — — CN claimed
CN-105132929-B A kind of hydrochloric acid pickling corrosion inhibitor and preparation method thereof 威海翔宇环保科技股份有限公司 2018-04-17 — — CN claimed
EP-3884019-A1 HOME CARE COMPOSITIONS Colgate-Palmolive Company (US) 2021-09-29 — — EP disclosed
CN-113227340-A Home care compositions 高露洁-棕榄公司 2021-08-06 — — CN disclosed
US-11008533-B2 Home care compositions COLGATE-PALMOLIVE COMPANY (US) 2021-05-18 — — US disclosed
US-20200208081-A1 HOME CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2020-07-02 — — US disclosed
WO-2020139335-A1 HOME CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2020-07-02 — — WO disclosed
CN-108623898-A The spacer bar of antimildew and antibacterial polypropylene material and preparation method with the application material 石家庄欧强节能建材科技有限公司 2018-10-09 — — CN disclosed
EP-2409704-B1 c-Met modulators and methods of use EXELIXIS INC (US) 2017-09-20 — — EP disclosed
CN-105753333-A Reflection reducing film on basis of silica sol for glass for heat collecting cover tubes and method for preparing reflection reducing film 山东中信能源联合装备股份有限公司 2016-07-13 — — CN disclosed
US-20130066029-A1 MULTI-METALLIC ORGANOMETALLIC COMPLEXES, AND RELATED POLYMERS, COMPOSITIONS, METHODS AND SYSTEMS CALIFORNIA INSTITUTE OF TECHNOLOGY 2013-03-14 — — US disclosed
US-20110306597-A1 Nicotinamide Derivatives CRAWFORTH JAMES MICHAEL (GB) 2011-12-15 — — US disclosed
CN-100345635-C Phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions DU PONT (CH) 2007-10-31 — — CN disclosed
CN-1307237-C Polymeric, phosphorous-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions DU PONT (CH) 2007-03-28 — — CN disclosed
CN-1617764-A Phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions DU PONT (US) 2005-05-18 — — CN disclosed
US-6002037-A INTERMEDIATES OF CHIRAL ORGANIC COMPOUNDS, E.G., ISOALKYL ALCOHOLS, IN HIGHLY ENANTIOMERIC EXCESS FOR PREPARING VITAMINS, DRUGS AND BIOMOLECULES; METALLOCENE CATALYSTS PURDUE RESEARCH FOUNDATION (US) 1999-12-14 — — US disclosed
EP-0091039-B1 ANTI-FOULING AGENT Nitto Kasei Co., Ltd. (JP) 1986-10-01 — — EP disclosed
US-4526932-A Copolymer containing N-coordinated triorganotin compound NITTO KASEI CO., LTD. (JP) 1985-07-02 — — US disclosed
EP-0091039-A2 Anti-fouling agent Nitto Kasei Co., Ltd. (JP) 1983-10-12 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130066029-A1 MULTI-METALLIC ORGANOMETALLIC COMPLEXES, AND RELATED POLYMERS, COMPOSITIONS, METHODS AND SYSTEMS PUF60, PICALM, PCBP1 TSHR 4774/4885ALDH1A1 3938/4885MEN1 971/4885
US-20110306597-A1 Nicotinamide Derivatives NNT, NAMPT, NQO1 TSHR 3631/4885ALDH1A1 172/4885MEN1 2257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.